Prostate Cancer Vaccines Market Size, Share & Industry Analysis, By Product (PROVENGE (sipuleucel-T) and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113610

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2024
Estimated Year	2025
Forecast Period	2025-2032
Historical Period	2019-2023
Growth Rate	CAGR of 12.0% from 2025-2032
Unit	Value (USD Million)
Segmentation	By Product PROVENGE (sipuleucel-T) Others
	By End User Hospitals Specialty Clinics Others
	By Geography North America (By Product, End User, and Country ) U.S. Canada Europe (By Product, End User, and Country/Sub-region) Germany U.K. France Spain Italy Rest of Europe Asia Pacific (By Product, End User, and Country/Sub-region) China Japan India Australia Rest of Asia Pacific Latin America (By Product, End User, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Product, End User, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa